C4 Therapeutics CCCC
NASDAQ CCCC
$3.14 -0.19 (-5.71%)
At close: Oct 1, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Depreciation & Amortization (CF) (2019 - 2026)

Updated

C4 Therapeutics (CCCC) reported Depreciation & Amortization (CF) of $292,000 for Q2 2026, down 52.5% from $615,000 a year earlier and down 27.7% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, C4 Therapeutics' Depreciation & Amortization (CF) came in at $1.58 million, down 20.5% year-over-year; for FY2025, it was $1.96 million, up 7.8% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.82 million in FY2024 (-3.3%), $1.88 million in FY2023 (+12.2%), $1.68 million in FY2022 (+12.3%) and $1.49 million in FY2021 (-7.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) in data going back to Q4 2019.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last three quarters, with an average decline of 2.6% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2023 (growth of 78.7%); the low point was Q2 2026 (a decline of 52.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $404,000 (Q1 2026), $428,000 (Q4 2025) and $460,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 C4 Therapeutics 409.28 Mn -520.48 Mn - 292,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 292,000.00
Mar 31, 2026 404,000.00
Dec 31, 2025 428,000.00
Sep 30, 2025 460,000.00
Jun 30, 2025 615,000.00
Mar 31, 2025 456,000.00
Dec 31, 2024 480,000.00
Sep 30, 2024 442,000.00
Jun 30, 2024 448,000.00
Mar 31, 2024 448,000.00
Dec 31, 2023 430,000.00
Sep 30, 2023 447,000.00
Jun 30, 2023 458,000.00
Mar 31, 2023 545,000.00
Dec 31, 2022 521,000.00
Sep 30, 2022 415,000.00
Jun 30, 2022 435,000.00
Mar 31, 2022 305,000.00
Dec 31, 2021 323,000.00
Sep 30, 2021 330,000.00
API Access

C4 Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CCCC&period=max&api_key=YOUR_API_KEY